Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Khalid Jazieh; Mohammadhadi Khorrami; Anas Saad; Mohamed Gad; Amit Gupta; Pradnya Patil; Vidya Sankar Viswanathan; Prabhakar Rajiah; Charles J Nock; Michael Gilkey; Pingfu Fu; Nathan A Pennell; Anant Madabhushi

doi:10.1136/jitc-2021-003778

Article info

Immunotherapy biomarkers

Original research

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Authors

Khalid Jazieh Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA PubMed articles Google scholar articles
Mohammadhadi Khorrami Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA PubMed articles Google scholar articles
Anas Saad Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articles Google scholar articles
Mohamed Gad Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA PubMed articles Google scholar articles
Amit Gupta Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA PubMed articles Google scholar articles
Pradnya Patil Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articles Google scholar articles
Vidya Sankar Viswanathan Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA PubMed articles Google scholar articles
Prabhakar Rajiah Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA PubMed articles Google scholar articles
Charles J Nock Louis Stokes Cleveland VA Medical Center Mental Health Services, Cleveland, Ohio, USA PubMed articles Google scholar articles
Michael Gilkey Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA PubMed articles Google scholar articles
Pingfu Fu Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA PubMed articles Google scholar articles
Nathan A Pennell Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA PubMed articles Google scholar articles
Anant Madabhushi Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USALouis Stokes Cleveland VA Medical Center Mental Health Services, Cleveland, Ohio, USA PubMed articles Google scholar articles

Citation

Jazieh K, Khorrami M, Saad A, et al

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Journal for ImmunoTherapy of Cancer 2022;10:e003778. doi: 10.1136/jitc-2021-003778

Online issue publication

January 25, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password